Christopher J. Johnson
- Global Cancer Incidence and Screening
- Economic and Financial Impacts of Cancer
- Cancer Risks and Factors
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Screening and Detection
- Advances in Oncology and Radiotherapy
- Biomedical Text Mining and Ontologies
- Cutaneous Melanoma Detection and Management
- Health disparities and outcomes
- Insurance, Mortality, Demography, Risk Management
- Health, Environment, Cognitive Aging
Survival from metastatic cutaneous melanoma is substantially lower than for localized disease. Treatments have been limited, but remarkable clinical improvements reported in trials the last decade. We described characteristics of US patients diagnosed with during 2001-2013 and assessed trends short-term survival distant-stage disease.Trends 1-year net were estimated using Pohar Perme estimator, controlling background mortality life tables all-cause rates by county residence, single year age,...
Abstract Background The National Cancer Institute funds many large cohort studies that rely on self-reported cancer data requiring medical record validation. This is labor intensive, costly, and prone to underreporting or misreporting of disparity-related differential response. US population-based central registries identify incident within their catchment area, yielding all malignant neoplasms benign brain nervous system tumors with standardized fields. manuscript describes the development,...